“并购之王”丹纳赫是如何“养成”的？

Core Insights - Danaher Corporation has successfully completed nearly 400 acquisitions over 40 years, spending approximately $90 billion, resulting in a market capitalization of about $200 billion and creating around $250 billion in shareholder value [2][4]. Acquisition Strategy - Danaher has a high frequency of acquisitions, averaging over 10 per year, with a peak of 19 in one year, and has never had a year without acquisitions [4]. - The company boasts a high success rate in acquisitions, with most large transactions being notably successful [4]. - Danaher operates across various industries, evolving from low-end manufacturing to advanced life sciences and diagnostics [4]. Evolution of Acquisition Style - In the 1980s, Danaher focused on high leverage and significant asset restructuring, later shifting to a strategy of seeking innovative and low-cost products [6]. - Under CEO Kalp, a core team was established, leading to a more scientific and structured acquisition process, integrating the Danaher Business System (DBS) into acquisition management [7][8]. Recent Trends - Post-2016, Danaher has focused on divesting non-core businesses and concentrating on life sciences and diagnostics, with over 95% of acquisition funds directed towards these sectors [11][12]. - The average number of acquisitions per year has decreased to 7.4, but the size of individual transactions has increased significantly, with an average deal size of $910 million [12]. - Danaher has also begun investing in early-stage technologies, establishing a venture capital arm to identify disruptive innovations [14]. Platform Strategy - Danaher employs a platform strategy, starting with a cornerstone asset to build a strategic business platform, followed by acquisitions of independent companies to enter adjacent markets [16]. - The water quality platform exemplifies this strategy, with significant acquisitions leading to substantial revenue growth and profitability [21][20]. Financial Performance - The water quality platform generated approximately $5 billion in revenue by 2022, with a return on invested capital (ROIC) exceeding 20% [21]. - The testing and measurement platform, which included notable acquisitions like Fluke and Tektronix, achieved significant financial success, contributing to Danaher's overall growth [23]. Sector-Specific Insights - The life sciences platform has become a focal point for Danaher, with substantial investments and acquisitions aimed at enhancing capabilities in this area [42]. - The in vitro diagnostics platform has also shown remarkable growth, with revenues reaching $9.6 billion and a profit margin of 27.4% [38][41].